Mpm Bioventures 2014, L.p. - Net Worth and Insider Trading
Mpm Bioventures 2014, L.p. Net Worth
The estimated net worth of Mpm Bioventures 2014, L.p. is at least $269 Million dollars as of 2024-11-13. Mpm Bioventures 2014, L.p. is the 10% Owner of ITeos Therapeutics Inc and owns about 13,822,380 shares of ITeos Therapeutics Inc (ITOS) stock worth over $127 Million. Mpm Bioventures 2014, L.p. is the 10% Owner of Entrada Therapeutics Inc and owns about 4,425,784 shares of Entrada Therapeutics Inc (TRDA) stock worth over $88 Million. Mpm Bioventures 2014, L.p. is also the of Harpoon Therapeutics Inc and owns about 1,611,361 shares of Harpoon Therapeutics Inc (HARP) stock worth over $37 Million. Besides these, Mpm Bioventures 2014, L.p. also holds Repare Therapeutics Inc (RPTX) , TCR2 Therapeutics Inc (TCRR) , Oncorus Inc (ONCR) . Details can be seen in Mpm Bioventures 2014, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mpm Bioventures 2014, L.p. has not made any transactions after 2022-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mpm Bioventures 2014, L.p.
Mpm Bioventures 2014, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mpm Bioventures 2014, L.p. owns 7 companies in total, including Oncorus Inc (ONCR) , ITeos Therapeutics Inc (ITOS) , and Repare Therapeutics Inc (RPTX) among others .
Click here to see the complete history of Mpm Bioventures 2014, L.p.’s form 4 insider trades.
Insider Ownership Summary of Mpm Bioventures 2014, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCR | Oncorus Inc | 2020-10-06 | 10 percent owner |
| ITOS | ITeos Therapeutics Inc | 2022-01-05 | 10 percent owner |
| RPTX | Repare Therapeutics Inc | 2020-06-23 | 10 percent owner |
 | | 2019-02-19 | 10 percent owner |
| | 2021-04-15 | 10 percent owner |
| | 2021-11-02 | 10 percent owner |
| | 2021-04-29 | 10 percent owner |
Mpm Bioventures 2014, L.p. Latest Holdings Summary
Mpm Bioventures 2014, L.p. currently owns a total of 6 stocks. Among these stocks, Mpm Bioventures 2014, L.p. owns 13,822,380 shares of ITeos Therapeutics Inc (ITOS) as of January 5, 2022, with a value of $127 Million and a weighting of 47.33%. Mpm Bioventures 2014, L.p. owns 4,425,784 shares of Entrada Therapeutics Inc (TRDA) as of November 2, 2021, with a value of $88 Million and a weighting of 32.6%. Mpm Bioventures 2014, L.p. also owns 1,611,361 shares of Harpoon Therapeutics Inc (HARP) as of April 15, 2021, with a value of $37 Million and a weighting of 13.8%. The other 3 stocks Repare Therapeutics Inc (RPTX) , TCR2 Therapeutics Inc (TCRR) , Oncorus Inc (ONCR) have a combined weighting of 6.27% among all his current holdings.
Latest Holdings of Mpm Bioventures 2014, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITOS | ITeos Therapeutics Inc | 2022-01-05 | 13,822,380 | 9.20 | 127,165,896 |
| TRDA | Entrada Therapeutics Inc | 2021-11-02 | 4,425,784 | 19.79 | 87,586,265 |
| HARP | Harpoon Therapeutics Inc | 2021-04-15 | 1,611,361 | 23.01 | 37,077,417 |
| RPTX | Repare Therapeutics Inc | 2020-06-23 | 3,003,772 | 3.50 | 10,498,183 |
| TCRR | TCR2 Therapeutics Inc | 2019-02-19 | 4,050,865 | 1.48 | 5,995,280 |
| ONCR | Oncorus Inc | 2020-10-06 | 2,849,453 | 0.13 | 359,031 |
Holding Weightings of Mpm Bioventures 2014, L.p.
Mpm Bioventures 2014, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Mpm Bioventures 2014, L.p. has made a total of 20 transactions in ITeos Therapeutics Inc (ITOS) over the past 5 years, including 2 buys and 18 sells. The most-recent trade in ITeos Therapeutics Inc is the sale of 146,685 shares on January 5, 2022, which brought Mpm Bioventures 2014, L.p. around $6 Million.
According to the SEC Form 4 filings, Mpm Bioventures 2014, L.p. has made a total of 1 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Entrada Therapeutics Inc is the acquisition of 100,000 shares on November 2, 2021, which cost Mpm Bioventures 2014, L.p. around $2 Million.
According to the SEC Form 4 filings, Mpm Bioventures 2014, L.p. has made a total of 7 transactions in Harpoon Therapeutics Inc (HARP) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Harpoon Therapeutics Inc is the sale of 467 shares on April 15, 2021, which brought Mpm Bioventures 2014, L.p. around $94,067.
More details on Mpm Bioventures 2014, L.p.'s insider transactions can be found in the Insider Trading History of Mpm Bioventures 2014, L.p. table.Insider Trading History of Mpm Bioventures 2014, L.p.
- 1
Mpm Bioventures 2014, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Mpm Bioventures 2014, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mpm Bioventures 2014, L.p. is 10.7%. GuruFocus also compares Mpm Bioventures 2014, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Mpm Bioventures 2014, L.p. within 3 months outperforms 3 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mpm Bioventures 2014, L.p.'s insider trading performs compared to the benchmark.
Performance of Mpm Bioventures 2014, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.86 | | | | | |
| Relative Return to S&P 500(%) | 16.83 | | | | | |
Mpm Bioventures 2014, L.p. Ownership Network
Ownership Network List of Mpm Bioventures 2014, L.p.
Ownership Network Relation of Mpm Bioventures 2014, L.p.
Mpm Bioventures 2014, L.p. Owned Company Details
What does Oncorus Inc do?
Who are the key executives at Oncorus Inc?
Mpm Bioventures 2014, L.p. is the 10 percent owner of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .
Oncorus Inc (ONCR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncorus Inc Insider Transactions
Mpm Bioventures 2014, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Mpm Bioventures 2014, L.p.. You might contact Mpm Bioventures 2014, L.p. via mailing address: C/o Mpm Asset Management Llc, 450 Kendall Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
